韩国引入13价肺炎球菌结合疫苗后侵袭性肺炎链球菌血清型分布及耐药性
本研究收集2017-2019年韩国16家医院411株侵袭性肺炎链球菌,分析血清型与耐药性。最常见血清型为3型(12.2%),PCV13覆盖率28.7%,红霉素耐药率80.3%,MDR占23.4%。非PCV13血清型增多,耐药随血清型而异,需持续监测。
要点
- 韩国侵袭性肺炎链球菌以3型(12.2%)最常见,PCV13覆盖率仅28.7%。
- 红霉素耐药率高达80.3%,MDR菌株占23.4%,以ST166和ST320为主。
- 非PCV13血清型增多,不同血清型耐药性存在差异,需持续监测。
核心结论
- 非PCV13血清型在侵袭性肺炎链球菌中增多,且耐药性因血清型而异,需持续监测。
研究设计与样本
- 收集2017-2019年韩国16家医院411株侵袭性肺炎链球菌,进行血清分型、药敏试验及MDR菌株多位点序列分型。
主要发现
- 最常见血清型为3型(12.2%),其次为10A(9.5%)、34(7.3%)、19A(6.8%)、23A(6.3%)等。
- PCV7、PCV10、PCV13和PPSV23覆盖率分别为7.8%、7.8%、28.7%和59.4%。
- 对青霉素、头孢曲松、红霉素和左氧氟沙星的耐药率分别为13.1%、9.2%、80.3%和4.1%。
- MDR菌株占23.4%,常见序列型为ST166(43.8%)和ST320(12.5%)。
关键数值与推荐
- 血清型23A、11A、19A和15B在MDR菌株中占比最高,分别为18.8%、16.7%、14.6%和8.3%。
临床怎么用
- 应持续监测侵袭性肺炎链球菌的血清型分布和抗菌药物耐药性,以指导感染管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Streptococcus pneumoniae is a serious pathogen causing various infections in humans. We evaluated the serotype distribution and antimicrobial resistance of S. pneumoniae causing invasive pneumococcal disease (IPD) after introduction of pneumococcal conjugate vaccine (PCV)13 in Korea and investigated the epidemiological characteristics of multidrug-resistant (MDR) isolates. METHODS: S. pneumoniae isolates causing IPD were collected from 16 hospitals in Korea between 2017 and 2019. Serotyping was performed using modified sequential multiplex PCR and the Quellung reaction. Antimicrobial susceptibility tests were performed using the broth microdilution method. Multilocus sequence typing was performed on MDR isolates for epidemiological investigations. RESULTS: Among the 411 S. pneumoniae isolates analyzed, the most prevalent serotype was 3 (12.2%), followed by 10A (9.5%), 34 (7.3%), 19A (6.8%), 23A (6.3%), 22F (6.1%), 35B (5.8%), 11A (5.1%), and others (40.9%). The coverage rates of PCV7, PCV10, PCV13, and pneumococcal polysaccharide vaccine (PPSV)23 were 7.8%, 7.8%, 28.7%, and 59.4%, respectively. Resistance rates to penicillin, ceftriaxone, erythromycin, and levofloxacin were 13.1%, 9.2%, 80.3%, and 4.1%, respectively. MDR isolates accounted for 23.4% of all isolates. Serotypes 23A, 11A, 19A, and 15B accounted for the highest proportions of total isolates at 18.8%, 16.7%, 14.6%, and 8.3%, respectively. Sequence type (ST)166 (43.8%) and ST320 (12.5%) were common among MDR isolates. CONCLUSIONS: Non-PCV13 serotypes are increasing among invasive S. pneumoniae strains causing IPD. Differences in antimicrobial resistance were found according to the specific serotype. Continuous monitoring of serotypes and antimicrobial resistance is necessary for the appropriate management of S. pneumoniae infections.
引用
- Kim GR, Kim EY, Kim SH, et al. Serotype Distribution and Antimicrobial Resistance of Streptococcus pneumoniae Causing Invasive Pneumococcal Disease in Korea Between 2017 and 2019 After Introduction of the 13-Valent Pneumococcal Conjugate Vaccine. Ann Lab Med. 2022. PMID: 36045056. doi:10.3343/alm.2023.43.1.45
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。